Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial-Reference-Cited by-同舟云学术

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Published:2005-01 Issue:9454 Volume:365 Page:123-129
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Janssen Harry LA,van Zonneveld Monika,Senturk Hakan,Zeuzem Stefan,Akarca Ulus S,Cakaloglu Yilmaz,Simon Christopher,So Thomas MK,Gerken Guido,de Man Robert A,Niesters Hubert GM,Zondervan Pieter,Hansen Bettina,Schalm Solko W

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa;Lau;Gastroenterology,1997

2. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection;Lin;Hepatology,1999

3. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B;Perrillo;N Engl J Med,1990

4. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis;Wong;Ann Intern Med,1993

5. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial [see comments];Schalm;Gut,2000

Cited by 1033 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation;European Journal of Gastroenterology & Hepatology;2024-07-22

2. Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon;Antiviral Research;2024-07

3. Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B;Liver Research;2024-07

4. Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence‐Based Review on Emerging Clinical Data;Clinical Pharmacology & Therapeutics;2024-04-30

5. Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future;Journal of Clinical Medicine;2024-04-02